Member Info for Owl11

Agreed that everything points towards J.V, although i suspect the team is smart enough to insert a break clause should other options become available and of interest.

72 x faster data analytics according to their website.

2021 was truly an epic year for Synairgen as we hit important milestones, grew the team and made preparations for the future.

Thank you to our partners for your continued support. Together we are ready to hit the ground running in 2022.

Taj Pharmaceuticals
@taj_pharma
World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — #remdesivir, #hydroxychloroquine, #lopinavir, & #interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19).
??info@tajpharma.com/+91 8448 444 095

https://twitter.com/taj_pharma/status/1478118244548595717?s=20

Coincidentally BBC News were just interviewing a doctor from a children's hospital in the states, patients are covid tested upon arrival regardless of condition which will obviously inflate cases, however he also said that regrettably children were also been admitted due to covid.

4th isn't a holiday, is it?

https://www.laverita.info/vaglio-pillole-anticovid-terapia-aerosol-2656170695.html?rebelltitem=1#rebelltitem1

SNG mention

https://twitter.com/Mike24775926/status/1472586123042070530?s=20

Can anyone translate this, might be absolutely nothing.

I don't expect results while early January however I wouldn't be surprised to see them earlier, I'm happy to be holding and very optimistic about our P3.

LungLube

Go on....

That's not what Whitty was saying today, he said nothing to suggest so far that this will impact children differently to other variants.

That's why I follow her Brand, as tenacious as they come.

This could be very interesting, let's remember he's probably seen the data in some form, imo.

I'd be disappointed with anything under 100ft!

I just can't see that Synairgen won't be pushing for info once data is un-blinded, why wouldn't you, they will be chomping at the bit for data.

All very interesting thanks for everyone's contribution.

Data will be ublinded so I'd like to think that a quick call from R.M to Parexel can reveal how promising the data looks, assume it shouldn't take long at all to get a good indication albeit not in a presentable form?

The folk with expertise I see talking on the news all appear quite unanimous that a massive increase in cases will cause increase in hospitalisation and death, unfortunately.

Potentially only 3 full trading days!

More coverage, hopefully gaining some momentum.

https://finance.yahoo.com/news/synairgen-presents-vitro-potency-data-210800696.html